PATENT CLAIM ANALYSIS

Application Number: 16178817
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-09
Patent Classification: ["514", "248000"]

Abstract:
3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4.

Claim (Index 9):
A compound according to  claim 1 , wherein\n R 1  and R 2  are independently selected from the group consisting of H and C 1-3 -alkyl optionally substituted with halogens, wherein at least one of R 1  or R 2  is independently C 1-3 -alkyl optionally substituted with halogens, or wherein R 1  and R 2  together form a 2- to 5-membered alkylene-bridge optionally substituted with halogens incorporating 0 to 2 heteroatoms independently selected from the group consisting of N, O or S.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.03333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14275879', '15685588', '15526361', '16048665', '15526360']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8543437246370589
- 35 USC 102 Novelty (BERT): 0.5675341862551906
- Combined Prediction Score: 0.8256627707988721
- Mean Citation Score: 427.91361400000005
- Max Citation Score: 444.39554
- Similarity Product: 424.9910123652256

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test